Summary: Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty® unlawfully infringes patents…
Pfizer and BioNTech
-
-
Global Market
Syniverse Is First to Offer a Cloud-Native, Hyperscale Digital Communications and Messaging Platform for Enterprises: Syniverse’s Hyperscale Communications Platform
by adminby adminSummary : New Syniverse CPaaS Platform to Accelerate Enterprises’ Digital Transformation and Improve Customer Experience The Syniverse Hyperscale Communications Platform allows enterprises…
-
Covid Drugs
US-Authorized COVID-19 Vaccines Generate More Than $30 Billion in 2021
by adminby adminSummary : The success of mRNA vaccines against COVID-19 has become a cash cow for Moderna, the Pfizer and BioNTech team and…
-
Although fractures normally heal, bone will not regenerate under several circumstances. When bone does not regenerate, major clinical problems could result, including…
-
Covid DrugsGlobal Market
Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed
by adminby adminSummary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences…
-
Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into…
-
CompaniesPfizer
Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety,…
-
CompaniesPfizer
Topical Combo based on Pfizer and Novartis Drugs advances after Clearing early Clinical test
by adminby adminSynopsis: Pfizer’s JAK inhibitor Xeljanz and Novartis’ S1P modulator Gilenya both have their share of safety problems. But Vyne Therapeutics thinks it…